Syndax Pharmaceuticals SNDX Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's total revenue?
- Syndax Pharmaceuticals (SNDX) reported total revenue of $64.86M in Q1 2026.
- How has Syndax Pharmaceuticals's total revenue changed year-over-year?
- Syndax Pharmaceuticals's total revenue increased by 223.6% year-over-year, from $20.04M to $64.86M.
- What is the long-term trend for Syndax Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's total revenue has grown at a 5.4% compound annual growth rate (CAGR), from $139.71M to $172.6M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.